Mach7 Technologies (M7T) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
27 Dec, 2025Executive summary
Contracted Annual Recurring Revenue (CAR/CARR) was AUD 30.8 million at March end, down 2.2% on a constant currency basis from the previous quarter.
Annual Recurring Revenue (ARR) run rate at end of March was AUD 24.4 million, down 1.9% sequentially, with sales orders for Q3 totaling AUD 5.1 million.
Cash receipts reached AUD 11.4 million in Q3, up 28% year-over-year and 18% sequentially, with operating cash flow positive at AUD 2.6 million.
Cash balance stood at AUD 24.9 million at quarter end, with no debt, and a share buyback commenced, acquiring 3.3 million shares to date.
CEO transition announced: Teri Thomas to become CEO from July 1, 2025.
Financial highlights
Q3 sales orders totaled AUD 5.1 million, with 67% from ARR-type sales, 12% from capital software, and 21% from professional services.
Operating cash inflow of AUD 2.6 million in Q3, up from AUD 900,000 in Q2; positive operating cash flow for the nine months to March 31.
Cost-out initiatives completed in Q3 are expected to deliver AUD 2–3 million in annualized savings.
Share buyback program underway, with 3.3 million shares repurchased to date for AUD 1.2 million.
Cash on hand increased to AUD 24.9 million at March end, up from AUD 23.6 million at December end.
Outlook and guidance
FY2025 guidance reaffirmed: 15%-25% growth in CAR/CARR and revenue, with OpEx growth below revenue growth.
Strong near-term sales pipeline supports guidance and target of 2–4 net new customer logos by year-end.
Expects continued demand and volume growth from new and existing customers across North America, APAC, and the Middle East.
Q3 cost-out initiatives expected to deliver AUD 2–3 million in annualized savings.
Expectation for a strong Q4 sales quarter to finish the year.
Latest events from Mach7 Technologies
- Revenue down 23% with strong margins; cost controls and Flamingo set stage for FY27 growth.M7T
H1 202627 Feb 2026 - Stable ARR, positive cash flow, and new product traction support a confident outlook.M7T
Q2 20263 Feb 2026 - Sales orders up 52%, recurring revenue and cash at record highs, subscription growth strong.M7T
Q4 2024 TU2 Feb 2026 - Record recurring revenue and sales orders drive positive cash flow amid subscription transition.M7T
H2 202423 Jan 2026 - CARR and ARR rose in Q1 FY25, with strong cash reserves and reaffirmed growth guidance.M7T
Q1 2025 TU17 Jan 2026 - Record sales and recurring revenue growth support a scalable, innovation-driven outlook for FY25.M7T
AGM 202412 Jan 2026 - Recurring revenue up 15.6%, strong cash, and FY25 growth guidance reaffirmed.M7T
Q2 2025 TU9 Jan 2026 - Revenue up 33%, recurring revenue covers 80% of OpEx, FY25 growth and buy-back reaffirmed.M7T
H1 202524 Dec 2025 - Solid FY 2025 results, leadership renewal, and AI-focused strategy set stage for global growth.M7T
AGM 202528 Nov 2025